Abstract:Stimuli-responsive nanocarriers attract wide attention because of the unique differences in microenvironment between solid tumors and normal tissues. Herein, we reported a novel cRGDyK peptide modified pH-sensitive nanoparticle system based on poly(ethylene glycol)-poly(2,4,6-trimethoxy benzylidene-pentaerythritol carbonate) (PEG-PTMBPEC) diblock copolymer, which was expected to destroy tumor angiogenesis and kill tumor cells simultaneously. Doxorubicin (DOX)-loaded nanoparticles (NPs) were characterized to have a uniform size distribution, high entrapment efficiency, good stability in plasma as well as a pH dependent drug release pattern. Blank NPs were non-toxic to both tumor cells and normal cells, while DOX-loaded cRGDyK peptide modified NPs (cRGDyK-NPs) exhibited the pronounced cytotoxicity against B16 cells and human umbilical vein endothelial cells (HUVEC) overexpressing alpha(v)beta(3) integrin receptors. Cellular uptake studies revealed that the highly efficient uptake of cRGDyK-NPs was attributed to the receptor-mediated endocytosis and acidic-triggered drug release. Importantly, cRGDyK-NPs could dramatically reduce the systemic toxicity of DOX and exert excellent tumor killing activity in vivo. The cRGDyK modified pH-sensitive nanocarrier is a promising vehicle for intracellular drug delivery to alpha(v)beta(3) integrin receptor overexpressed tumor cells and neovascular cells.Statement of SignificanceSlow intracellular drug release and poor tumor targeting capacity are still the critical barriers of polymeric nanoparticles (NPs) for the treatment efficiency of chemotherapy. In the present study, we designed cRGDyK peptide modified poly(ethylene glycol)-poly(2,4,6-trimethoxybenzylidene-pentaery thritol carbonate) (cRGDyK-PEG-PTMBPEC) NPs with active targeting and fast pH-triggered drug release. Doxorubicin (DOX)-loaded cRGDyK-PEG-PTMBPEC NPs exhibited pronounced cytotoxicity and enhanced cellular uptake against B16 cells and human umbilical vein endothelial cells overexpressing alpha v beta 3 integrin receptors. Moreover, the active targeted pH-sensitive NPs can enhance the antitumor activity and reduce the systematic toxicity of DOX in vivo. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

A Reactive Oxygen Species-Responsive Poly(amino acids) Nanoparticle Loading Doxorubicin for Glioblastoma Multiforme Treatment.

Oxidation Responsive PEGylated Polyamino Acid Bearing Thioether Pendants for Enhanced Anticancer Drug Delivery.

A Targeted and Responsive Nanoprodrug Delivery System for Synergistic Glioma Chemotherapy

Construction of Poly(amino Acid)s Nano-Delivery System and Sustained Release with Redox-Responsive

Reactive oxygen species-responsive amino acid-based polymeric nanovehicles for tumor-selective anticancer drug delivery

Programmed Ph/reduction-Responsive Nanoparticles for Efficient Delivery of Antitumor Agents in Vivo.

Redox-responsive nanomedicine of doxorubicin-conjugated poly-L-glutathione oxidized for cancer therapy

LRP1-mediated Ph-Sensitive Polymersomes Facilitate Combination Therapy of Glioblastoma in Vitro and in Vivo

Nanoscaled Poly(l-Glutamic Acid)/doxorubicin-Amphiphile Complex As Ph-Responsive Drug Delivery System for Effective Treatment of Nonsmall Cell Lung Cancer.

ROS and GSH-responsive S-nitrosoglutathione Functionalized Polymeric Nanoparticles to Overcome Multidrug Resistance in Cancer.

Hydrophilic Poly(Glutamic Acid)-Based Nanodrug Delivery System: Structural Influence and Antitumor Efficacy

Co-delivery of PLK1-specific shRNA and doxorubicin via core-crosslinked pH-sensitive and redox ultra-sensitive micelles for glioma therapy

Thermo/redox/pH-triple Sensitive Poly(n-Isopropylacrylamide-co-acrylic Acid) Nanogels for Anticancer Drug Delivery.

Multistimuli-responsive PEGylated Polymeric Bioconjugate-Based Nano-Aggregate for Cancer Therapy

Lactoferrin/phenylboronic Acid-Functionalized Hyaluronic Acid Nanogels Loading Doxorubicin Hydrochloride for Targeting Glioma.

Bioinspired Nanoplatform for Enhanced Delivery Efficiency of Doxorubicin into Nucleus with Fast Endocytosis, Lysosomal Ph-Triggered Drug Release, and Reduced Efflux.

Precise engineering of dual drug-loaded polymeric nanoparticles system to improve the treatment of glioma-specific targeting therapy

ROS-Switchable Polymeric Nanoplatform with Stimuli-Responsive Release for Active Targeted Drug Delivery to Breast Cancer.

A new biosafe reactive oxygen species (ROS)-responsive nanoplatform for drug delivery

Enzymatic synthesis of PEG–poly(amine-co-thioether esters) as highly efficient pH and ROS dual-responsive nanocarriers for anticancer drug delivery

Crgdyk Modified Ph Responsive Nanoparticles for Specific Intracellular Delivery of Doxorubicin.